SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 143 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.98 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $27,767 | -66.1% | 1,201 | -61.5% | 0.00% | -66.7% |
Q2 2023 | $81,858 | +166957.1% | 3,122 | +64.3% | 0.00% | +50.0% |
Q1 2023 | $49 | -83.1% | 1,900 | -83.0% | 0.00% | -83.3% |
Q4 2022 | $290 | -99.6% | 11,146 | +330.3% | 0.01% | +1100.0% |
Q3 2022 | $74,000 | -78.6% | 2,590 | -81.6% | 0.00% | -87.5% |
Q2 2022 | $346,000 | -0.3% | 14,083 | +128.7% | 0.01% | +166.7% |
Q1 2022 | $347,000 | -0.6% | 6,158 | +9.3% | 0.00% | -50.0% |
Q4 2021 | $349,000 | +47.3% | 5,633 | +50.9% | 0.01% | 0.0% |
Q3 2021 | $237,000 | -35.6% | 3,732 | -16.3% | 0.01% | -40.0% |
Q2 2021 | $368,000 | +503.3% | 4,458 | +437.1% | 0.01% | +900.0% |
Q1 2021 | $61,000 | -11.6% | 830 | -12.8% | 0.00% | -50.0% |
Q4 2020 | $69,000 | -86.6% | 952 | -91.2% | 0.00% | -66.7% |
Q3 2020 | $516,000 | +416.0% | 10,815 | +356.3% | 0.01% | +50.0% |
Q2 2020 | $100,000 | +354.5% | 2,370 | +133.7% | 0.00% | +100.0% |
Q3 2019 | $22,000 | – | 1,014 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 5,831,307 | $480,558,000 | 31.49% |
Consonance Capital Management LP | 1,199,339 | $98,838,000 | 11.90% |
Boxer Capital, LLC | 2,075,905 | $171,075,000 | 6.04% |
Perceptive Advisors | 9,699,824 | $799,362,000 | 5.19% |
Orbimed Advisors | 6,044,266 | $498,108,000 | 5.04% |
Samsara BioCapital, LLC | 169,852 | $13,998,000 | 1.73% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 1,375,775 | $113,378,000 | 1.50% |
SPHERA FUNDS MANAGEMENT LTD. | 195,117 | $16,080,000 | 1.09% |
Artal Group S.A. | 500,000 | $41,205,000 | 0.84% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 558,574 | $46,032,000 | 0.82% |